ICSMA-21-012-01

Vulnerability from csaf_cisa - Published: 2021-01-12 00:00 - Updated: 2021-01-12 00:00
Summary
SOOIL Dana Diabecare RS Products

Notes

CISA Disclaimer
This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov
Legal Notice
All information products included in https://us-cert.cisa.gov/ics are provided "as is" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.
Risk evaluation
Successful exploitation of these vulnerabilities could allow an attacker to access sensitive information, modify therapy settings, bypass authentication, or crash the device being accessed. These vulnerabilities could affect patient safety.
Critical infrastructure sectors
Healthcare and Public Health
Countries/areas deployed
Europe, Asia
Company headquarters location
South Korea
Recommended Practices
CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:
Recommended Practices
CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities.CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures. CISA also provides a section for control systems security recommended practices on the ICS webpage onus-cert.cisa.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Recommended Practices
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.cisa.gov in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies. Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.
Exploitability
No known public exploits specifically target these vulnerabilities.
To clipboard 

{
  "document": {
    "acknowledgments": [
      {
        "names": [
          "Julian Suleder",
          "Birk Kauer",
          "Raphael Pavlidis",
          "Nils Emmerich"
        ],
        "organization": "ERNW Research GmbH",
        "summary": "reporting these vulnerabilities to the Federal Office for Information Security (BSI, Germany), in the context of the BSI project ManiMed - Manipulation of Medical Devices"
      },
      {
        "organization": "BSI",
        "summary": "providing this report to CISA"
      }
    ],
    "category": "csaf_security_advisory",
    "csaf_version": "2.0",
    "distribution": {
      "text": "Disclosure is not limited",
      "tlp": {
        "label": "WHITE",
        "url": "https://us-cert.cisa.gov/tlp/"
      }
    },
    "lang": "en-US",
    "notes": [
      {
        "category": "general",
        "text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
        "title": "CISA Disclaimer"
      },
      {
        "category": "legal_disclaimer",
        "text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
        "title": "Legal Notice"
      },
      {
        "category": "summary",
        "text": "Successful exploitation of these vulnerabilities could allow an attacker to access sensitive information, modify therapy settings, bypass authentication, or crash the device being accessed. These vulnerabilities could affect patient safety.",
        "title": "Risk evaluation"
      },
      {
        "category": "other",
        "text": "Healthcare and Public Health",
        "title": "Critical infrastructure sectors"
      },
      {
        "category": "other",
        "text": "Europe, Asia",
        "title": "Countries/areas deployed"
      },
      {
        "category": "other",
        "text": "South Korea",
        "title": "Company headquarters location"
      },
      {
        "category": "general",
        "text": "CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities.CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.\nCISA also provides a section for control systems security recommended practices on the ICS webpage onus-cert.cisa.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.cisa.gov in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.\nOrganizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.",
        "title": "Recommended Practices"
      },
      {
        "category": "other",
        "text": "No known public exploits specifically target these vulnerabilities.",
        "title": "Exploitability"
      }
    ],
    "publisher": {
      "category": "coordinator",
      "contact_details": "Email: CISAservicedesk@cisa.dhs.gov;\n Toll Free: 1-888-282-0870",
      "name": "CISA",
      "namespace": "https://www.cisa.gov/"
    },
    "references": [
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-21-012-01 JSON",
        "url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2021/icsma-21-012-01.json"
      },
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-21-012-01 Web Version",
        "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-012-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-012-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://us-cert.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://us-cert.cisa.gov/ics/tips/ICS-TIP-12-146-01B"
      }
    ],
    "title": "SOOIL Dana Diabecare RS Products",
    "tracking": {
      "current_release_date": "2021-01-12T00:00:00.000000Z",
      "generator": {
        "engine": {
          "name": "CISA CSAF Generator",
          "version": "1.0.0"
        }
      },
      "id": "ICSMA-21-012-01",
      "initial_release_date": "2021-01-12T00:00:00.000000Z",
      "revision_history": [
        {
          "date": "2021-01-12T00:00:00.000000Z",
          "legacy_version": "Initial",
          "number": "1",
          "summary": "ICSMA-21-012-01 SOOIL Dana Diabecare RS"
        }
      ],
      "status": "final",
      "version": "1"
    }
  },
  "product_tree": {
    "branches": [
      {
        "branches": [
          {
            "branches": [
              {
                "category": "product_version_range",
                "name": "\u003c 3.0",
                "product": {
                  "name": "AnyDana-A: All versions prior to 3.0",
                  "product_id": "CSAFPID-0001"
                }
              }
            ],
            "category": "product_name",
            "name": "AnyDana-A"
          },
          {
            "branches": [
              {
                "category": "product_version_range",
                "name": "\u003c 3.0",
                "product": {
                  "name": "Dana Diabecare RS: All versions prior to 3.0",
                  "product_id": "CSAFPID-0002"
                }
              }
            ],
            "category": "product_name",
            "name": "Dana Diabecare RS"
          },
          {
            "branches": [
              {
                "category": "product_version_range",
                "name": "\u003c 3.0",
                "product": {
                  "name": "AnyDana-i: All versions prior to 3.0",
                  "product_id": "CSAFPID-0003"
                }
              }
            ],
            "category": "product_name",
            "name": "AnyDana-i"
          }
        ],
        "category": "vendor",
        "name": "SOOIL Developments Co, Ltd."
      }
    ]
  },
  "vulnerabilities": [
    {
      "cve": "CVE-2020-27256",
      "cwe": {
        "id": "CWE-798",
        "name": "Use of Hard-coded Credentials"
      },
      "notes": [
        {
          "category": "summary",
          "text": "A hard-coded physician PIN in the physician menu of the insulin pump allows attackers with physical access to change insulin therapy settings.CVE-2020-27256 has been assigned to this vulnerability. A CVSS v3 base score of 4.6 has been calculated; the CVSS vector string is (AV:P/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27256"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 4.6,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2020-27258",
      "cwe": {
        "id": "CWE-522",
        "name": "Insufficiently Protected Credentials"
      },
      "notes": [
        {
          "category": "summary",
          "text": "An information disclosure vulnerability in the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows unauthenticated attackers to extract the pump \u0027s keypad lock PIN via Bluetooth Low Energy.CVE-2020-27258 has been assigned to this vulnerability. A CVSS v3 base score of 6.5 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27258"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 6.5,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2020-27264",
      "cwe": {
        "id": "CWE-330",
        "name": "Use of Insufficiently Random Values"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications use deterministic keys, which allows unauthenticated, physically proximate attackers to brute-force the keys via Bluetooth Low Energy.CVE-2020-27264 has been assigned to this vulnerability. A CVSS v3 base score of 7.6 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:L).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27264"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:L"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 7.6,
            "baseSeverity": "HIGH",
            "vectorString": "CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:L",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2020-27266",
      "cwe": {
        "id": "CWE-603",
        "name": "Use of Client-Side Authentication"
      },
      "notes": [
        {
          "category": "summary",
          "text": "A client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass user authentication checks via Bluetooth Low Energy.CVE-2020-27266 has been assigned to this vulnerability. A CVSS v3 base score of 6.5 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27266"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 6.5,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2020-27268",
      "cwe": {
        "id": "CWE-602",
        "name": "Client-Side Enforcement of Server-Side Security"
      },
      "notes": [
        {
          "category": "summary",
          "text": "A client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass checks for default PINs via Bluetooth Low Energy.CVE-2020-27268 has been assigned to this vulnerability. A CVSS v3 base score of 6.5 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27268"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 6.5,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2020-27269",
      "cwe": {
        "id": "CWE-294",
        "name": "Authentication Bypass by Capture-replay"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physically proximate attackers to replay communication sequences via Bluetooth Low Energy.CVE-2020-27269 has been assigned to this vulnerability. A CVSS v3 base score of 5.4 has been calculated; the CVSS vector string is (AV:A/AC:H/PR:N/UI:R/S:U/C:L/I:H/A:N).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27269"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:H/PR:N/UI:R/S:U/C:L/I:H/A:N"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 5.4,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:A/AC:H/PR:N/UI:R/S:U/C:L/I:H/A:N",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2020-27270",
      "cwe": {
        "id": "CWE-523",
        "name": "Unprotected Transport of Credentials"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications does not use adequate measures to protect encryption keys in transit, which allows unauthenticated, physically proximate attackers to sniff the keys via Bluetooth Low Energy.CVE-2020-27270 has been assigned to this vulnerability. A CVSS v3 base score of 5.7 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27270"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 5.7,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2020-27272",
      "cwe": {
        "id": "CWE-322",
        "name": "Key Exchange without Entity Authentication"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications does not use adequate measures to authenticate the pump before exchanging keys, which allows unauthenticated, physically proximate attackers to eavesdrop the keys and spoof the pump via Bluetooth Low Energy.CVE-2020-27272 has been assigned to this vulnerability. A CVSS v3 base score of 5.7 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27272"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 5.7,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2020-27276",
      "cwe": {
        "id": "CWE-290",
        "name": "Authentication Bypass by Spoofing"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications does not use adequate measures to authenticate the communicating entities before exchanging keys, which allows unauthenticated, physically proximate attackers to eavesdrop the authentication sequence via Bluetooth Low Energy.CVE-2020-27276 has been assigned to this vulnerability. A CVSS v3 base score of 5.7 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27276"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 5.7,
            "baseSeverity": "MEDIUM",
            "vectorString": "CVSS:3.0/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    }
  ]
}


Log in or create an account to share your comment.




Tags
Taxonomy of the tags.




Sightings

Author Source Type Date

Nomenclature

  • Seen: The vulnerability was mentioned, discussed, or observed by the user.
  • Confirmed: The vulnerability has been validated from an analyst's perspective.
  • Published Proof of Concept: A public proof of concept is available for this vulnerability.
  • Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
  • Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
  • Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
  • Not confirmed: The user expressed doubt about the validity of the vulnerability.
  • Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.



Detection rules are retrieved from Rulezet.